Literature DB >> 7793481

Mucoepidermoid carcinomas of the thymus. A clinicopathologic study of six cases.

C A Moran1, S Suster.   

Abstract

Six cases of mucoepidermoid carcinoma of the thymus are presented. The patients were two men and four women aged 17 to 66 years (median age, 34.5). Clinically, three patients had symptoms of chest discomfort and three were asymptomatic. Grossly, the tumors in three patients were described as cystic structures varying in size from 7 to 8 cm in greatest dimension, with focal areas of induration within the walls of the cyst that averaged from 1.5 to 3 cm. The other three cases had grossly and radiographically well-circumscribed, homogeneous tumor masses. Histologically, the lesions showed a spectrum of features that ranged from those of well-differentiated, to moderately well-differentiated, to poorly differentiated mucoepidermoid carcinoma, with sheets and solid islands of squamoid cells admixed with mucin-secreting epithelium lining gland-like spaces. In four cases, the tumor was histologically seen in continuity with the epithelial lining of multilocular cystic structures; the nonneoplastic components of the cysts contained abundant inflammation and showed the features of otherwise conventional acquired multilocular thymic cysts. Clinical follow-up showed that the two patients with intermediate and high-grade tumors died within 2 and 7 months after initial diagnosis. One of these patients showed at autopsy residual tumor limited to the mediastinum, whereas the other patient died with metastases to pericardium and myocardium despite postoperative radiation therapy. Two patients with low-grade tumors were alive and well with no residual disease 2 and 3 years after surgery, and the other two were lost to follow-up. Mucoepidermoid carcinoma of the thymus should be included in the differential diagnosis of cystic neoplasms of the thymus. As with their counterparts at other sites, the biologic behavior of these tumors closely correlates with their degree of differentiation and amount of cytologic atypia.

Entities:  

Mesh:

Year:  1995        PMID: 7793481     DOI: 10.1097/00000478-199507000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Primary MALT-type lymphoma of the thymus: a clinicopathological and immunohistochemical study of six cases.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  Lung       Date:  2011-10-12       Impact factor: 2.584

Review 2.  Thymic adenocarcinoma associated with thymic cyst: a case report and review of literature.

Authors:  Leiming Wang; Dandan Wang; Kun Qian; Dehong Lu; Li Chen; Lan Zhao; Lianghong Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  [Thymic cyst with initial malignant transformation].

Authors:  A Morresi-Hauf; W Wöckel; T Kirchner
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

4.  Mucoepidermoid carcinoma of the thymus.

Authors:  Manabu Yasuda; Tomohisa Yasukawa; Daisuke Ozaki; Toshikazu Yusa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-01

5.  Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases.

Authors:  Xuxia Shen; Yan Jin; Lei Shen; Yihua Sun; Haiquan Chen; Yuan Li
Journal:  Diagn Pathol       Date:  2018-06-26       Impact factor: 2.644

Review 6.  Thymic Carcinoma: A Review.

Authors:  Doaa Alqaidy; Cesar A Moran
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

7.  Mucoepidermoid carcinoma of the thymus: a case report.

Authors:  Gang-Deuk Kim; Hye-Won Kim; Jung-Taek Oh; Hyang-Jeong Jo; Seon-Kwan Juhng
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

8.  Mucoepidermoid carcinoma of the thymus incidentally diagnosed following two-years of non-productive cough.

Authors:  Ryan Thibodeau; Abtin Jafroodifar; Marlon Coelho; Benjamin Kaminski; Lorenzo Gitto; Daniel J Zaccarini; Ernest Scalzetti
Journal:  Radiol Case Rep       Date:  2021-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.